Annual report pursuant to Section 13 and 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.20.1
Description of Business and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of cash and cash equivalent and restricted cash
    December 31,
2019		     December 31,
2018		  
Cash and cash equivalents   $ 9,253,831     $ 13,673,308  
Restricted cash – current     48,092       40,075  
Restricted cash – long term     391,327       391,131  
Cash and cash equivalent and restricted cash   $ 9,693,250     $ 14,104,514  
Schedule of antidilutive securities excluded from computation of diluted net loss per share

    December 31,
2019		     December 31,
2018		  
Options     11,385,301       7,236,101  
Warrants     86,140,575       55,820,876  
Total     97,525,876       63,056,977